Denver, Colorado, USA – May 18, 2017 – Today at the 2017 Annual Arthroscopy Association of North America (AANA) Meeting (booth #109), Stryker’s Sports Medicine business and AlloSource® formally announced their collaboration to provide high quality, innovative biologics for use in sports medicine procedures. This collaboration is driven by the companies’ combined commitment to better serve their customers, help patients in need and fully honor the gift of tissue donation.
“We believe biologics will play a critical role in advancing the field of Sports Medicine, so we are very excited about the opportunity to collaborate with AlloSource given their history of quality and innovation,” said Matt Moreau, Vice President & General Manager of Stryker’s Sports Medicine business. “The collaboration between Stryker and AlloSource will enable us to combine our unique areas of expertise to develop new ways to improve patient outcomes.”
Through the collaboration, Stryker’s Sports Medicine nationwide sales force will distribute AlloSource biologics for use in a variety of sports medicine procedures.
“Deepening our relationship with Stryker through this sports medicine collaboration will help us further advance patient healing and honor our tissue donors by getting biologics in the hands of more surgeons,” said Kerr Holbrook, AlloSource Chief Commercial Officer. “We look forward to working and growing together.”